# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-042011
Filing Date
2025-05-12
Accepted
2025-05-12 16:01:15
Documents
70
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | QUARTERLY REPORT | ea0239735-10q_jasper.htm iXBRL | 10-Q | 712637
2 | CERTIFICATION | ea023973501ex31-1_jasper.htm | EX-31.1 | 11226
3 | CERTIFICATION | ea023973501ex31-2_jasper.htm | EX-31.2 | 11041
4 | CERTIFICATION | ea023973501ex32-1_jasper.htm | EX-32.1 | 7016
| Complete submission text file | 0001213900-25-042011.txt |  | 4725908

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | jspr-20250331.xsd | EX-101.SCH | 49974
6 | XBRL CALCULATION FILE | jspr-20250331_cal.xml | EX-101.CAL | 34142
7 | XBRL DEFINITION FILE | jspr-20250331_def.xml | EX-101.DEF | 225598
8 | XBRL LABEL FILE | jspr-20250331_lab.xml | EX-101.LAB | 412701
9 | XBRL PRESENTATION FILE | jspr-20250331_pre.xml | EX-101.PRE | 233176
72 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0239735-10q_jasper_htm.xml | XML | 451092

Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Filer) CIK: 0001788028 (see all company filings)

EIN.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39138 | Film No.: 25934584
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)